- Statement of responsibility by board of directors
- Statement by the company secretary
- Audit and Risk Committee Report
- Report of the independent auditor
- Report of the board of directors
- Accounting policies
- Balance sheets
- Income statements
- Statements of changes in equity
- Cash flow statements
- Notes to the annual financial statements
- Annexure A – Principal subsidiary companies
- Annexure B – Principal investments
- Annexure C – Significant associated companies
- Annexure D – Information on business and geographical segments
Sustainability Report
HIV/AIDS POLICY
From an investment holding company perspective, the risk of HIV/Aids comprises two elements, namely:Group risk
Given the potential impact of HIV/Aids on the markets, on human capital, cost of employment and on the operational processes of the various businesses invested in, this risk is managed within the governance structures of the various investee companies.
The progress of these policies and strategies is monitored against best practice standards.
Company risk
Remgro has a formal HIV/Aids policy and is committed to manage the pandemic, and the business risks associated with it, actively. The policy makes provision, inter alia, for the following:
- Compliance with all legal requirements as far as HIV/Aids is concerned
- No discrimination against employees or potential employees based on their HIV status
- Strict confidential treatment of information on the HIV status of employees
- General measures to prevent accidental infection
Remedi Medical Aid Scheme, of which most of Remgro’s staff are members, has a management plan for HIV/Aids in which employees can choose to participate. M&I, as specialised service company, employs all the staff of Remgro.